Great businesses at fair prices — here's why each makes the list.
…and 368 more buy candidates in the full briefing.
42 name(s) sliding toward Avoid:
Value $105,571 ▲ +5.6% since 2026-07-16 · ▼ -$0 (-0.0%) since yesterday · S&P +2.2% · Cash $3,897
| Stock | Held | Price | Today | Since buy | Grade |
| CF | 83 sh | $133.35 | ▼ -3.2% | +2.9% | 89 |
| EOG | 78 sh | $145.19 | ▼ -0.5% | +7.8% | 87 |
| FHI | 156 sh | $62.40 | ▲ +0.4% | +4.1% | 92 |
| HIG | 73 sh | $138.37 | ▼ -1.2% | +1.3% | 90 |
| INTU | 33 sh | $332.70 | ▼ -3.4% | +12.9% | 87 |
| LOPE | 69 sh | $152.67 | ▲ +0.1% | +6.6% | 89 |
| LULU | 85 sh | $100.61 | ▼ -17.4% | -15.4% | 87 |
| NBIX | 58 sh | $155.64 | ▼ -1.7% | -9.3% | 89 |
| PRI | 31 sh | $295.62 | ▼ -0.7% | -5.5% | 93 |
| RMD | 49 sh | $228.35 | ▼ -0.4% | +12.6% | 84 |
Fictional money · prices update daily · a live test of whether the picks actually work.
Does the grading actually work? Two honest halves — a backtest on past data, and the real live record as it ripens. It reports the truth even when that's “not enough data yet.”
Reconstructed 318 graded moments across 150 companies (a sample of 150 names), then measured what each actually returned over the next 12 months.
Do higher grades earn better returns?
| Grade | Names | 12-mo return | vs S&P |
| A (80-100) | 45 | +14.9% | +1.5% |
| B (65-79) | 159 | +11.3% | -4.2% |
| C (50-64) | 90 | +12.7% | -1.6% |
| D-F (<50) | 24 | +41.0% | +27.2% |
→ higher grades did WORSE here (gap 26.1 pts) ⚠️
37 snapshot(s) since 2026-07-06, none ripe yet — first 6-month check ~2027-01-06.
Backtest limits: ~5 years back, surviving companies only, restated statements — a strong first read, not gospel. The live record is the hindsight-free gold standard and strengthens every month. Refreshed 2026-09-06. Educational only — not financial advice.
Big week — and not in a good way. Lululemon's stock has cratered ~50% year-to-date. Last week's Q2 earnings report was the catalyst: the company cut its full-year guidance after admitting that negative social media buzz hurt store traffic. Leggings sales fell 20%, the Americas segment (about two-thirds of revenue) dropped 8%, and international same-store sales slipped 3%. On top of that, founder Chip Wilson's divorce was reported, raising questions about potential forced selling of his large stake. New CEO Heidi O'Neill is now in the hot seat. Multiple analysts slashed price targets — JPMorgan cut by 38%, and Truist projected 18% further downside. Michael Burry reportedly sees the depressed price as a turnaround opportunity. The SEC 8-K filed Sept 3 likely relates to the earnings results and executive transition.
This is a real fundamental deterioration, not just noise. The grade (87.4) reflects strong profitability and financials built up over years, but the guidance cut and brand headwinds are very recent — the grade may adjust downward as updated data flows through. Worth watching closely; the numbers and the narrative are pulling in opposite directions right now.
A Zacks article flagged an interesting tension: Primerica's investment business is booming (Q2 net income up 13% to $202M), but the sales force — the agent network that drives customer acquisition — is shrinking. The article calls it "two different companies bolted together." Separately, the stock is down ~8.8% since its last earnings report, possibly from profit-taking after a strong run. A Zacks upgrade to Buy was also noted.
For a company graded 93, the shrinking-agent concern is worth watching over coming quarters, but it's not an emergency — earnings are still growing and the balance sheet is rock-solid. Noise for now, monitor for trend.
The stock hit a new record in early September on a fertilizer supply crunch (per WSJ), and is up 18.1% since last earnings. The company also filed an SEC 8-K on Sept 3 (the filing itself was blocked by SEC.gov — likely a routine event such as a leadership transition or compensation disclosure, since a separate headline noted the CFO-level accounting chief plans a 2027 retirement). CF Industries is also being talked up as "still undervalued" in a Seeking Alpha piece, and featured in IBD screens for market leadership shifts. Its low-carbon pivot is attracting Street support.
The supply-crunch tailwind is a real, external catalyst that supports the already-strong fundamentals. No red flags here.
Deckers is expanding its direct-to-consumer (DTC) business, which supports higher margins than wholesale. The HOKA and UGG brands continue to drive growth. Multiple valuation articles suggest the stock still trades below fair value despite strong returns on capital and cash flow. A director added to their stake (insider buying is generally a positive signal). Meanwhile, competitor Lululemon's 17% crash on Sept 4 and On Holding's mixed results provide some read-through on athletic/lifestyle apparel demand, but Deckers' HOKA brand appears to be in a different, stronger position.
Mostly positive noise — the DTC shift is a real, margin-improving trend.
The main story is Federated Hermes' push into tokenization in Asia-Pacific via a partnership with Conduit, positioned as a potential new lever for growing assets under management (AUM). Brokerages have a consensus "Moderate Buy." No material negative news.
The tokenization initiative is interesting but early-stage — it's an optionality play, not yet a driver. The core money-market business remains the bread and butter.
Hartford partnered with UC Berkeley's Bakar Labs to support early-stage energy and materials startups, providing risk management expertise. This gives Hartford early access to emerging risk categories — a modest strategic positive. A Simply Wall St analysis says the stock looks like a bargain on earnings. No material negative news — mostly institutional buying activity and routine trading-day performance articles.
Quiet week. The partnership is a small strategic positive, nothing urgent.
A Yahoo Finance article described LOPE as "a steady cash-generating business ignored in a speculative market" — consistent with its high grade. However, a Simply Wall St piece flagged an interim CFO appointment amid a "trading probe," which could be a governance concern worth tracking. The rest is institutional buying noise.
The trading probe headline warrants attention — couldn't load the full article (Google News redirect), but any regulatory scrutiny of a company's trading practices is a real risk. The grade doesn't capture governance risk.
Neurocrine will present at investor conferences in September (Boston, New York). A Simply Wall St piece says the stock "could still be a bargain after a 61% run." A director donated 1,000 shares (charitable giving, not a sell signal). No material negative news.
Quiet week. Conference presentations could produce catalysts but nothing concrete yet.
Raymond James expanded its board and declared a quarterly dividend (per an SEC 8-K filed Sept 1 — SEC.gov blocked the filing, but the Globe and Mail headline confirms these events). The firm also named top banking stock picks and resumed coverage of Ally Financial with a Strong Buy. Routine institutional buying noted.
Steady, no concerns. Board expansion and dividend declaration are standard corporate housekeeping.
Kinsale's small-account strategy in the E&S (excess and surplus) insurance market is working: over half of its divisions achieved double-digit submission growth in Q2, and nine new products launched in H1 2026. The combined ratio of 75.5% is excellent (below 100% means the insurance business is profitable before investment income). However, brokerages have a consensus "Reduce" rating, which creates a tension with the tool's Buy grade. The stock appears to trade below fair value based on strong returns.
The analyst consensus "Reduce" is notable and worth understanding — it may reflect valuation concerns at current levels even though the underlying business is strong.
Iron Mountain is pivoting hard into AI-powered data center services, with a Saudi Arabia expansion (AI digital partnership) and a revenue surge (Q2 revenue $2.03B, up 18.5% YoY, swinging back to profitability). Analysts boosted the fair value estimate to ~$146 on higher AI growth assumptions. However, the stock is still down 5.7% since last earnings. Virginia Retirement Systems took a $55.8M position.
The AI pivot is real and the revenue growth is impressive, but the low grade (39.3) reflects that the valuation has gotten very stretched — the stock price has run ahead of what the fundamentals currently justify. Classic case where news is bullish but the grade says "too expensive."
Down 15% since last earnings. A Seeking Alpha piece argues debt reduction creates a long-term value opportunity (upgrade). But the low grade reflects weak fundamentals, and the competitive environment (SharkNinja gaining share) is tough. No game-changing catalyst either way.
Still struggling. The debt-reduction angle is real but it's a slow process in a difficult market.
Down 3% since last earnings. An analyst upgraded the stock (no longer bearish), and it got a brief boost from the Fervo Energy / Google power deal news (geothermal energy peer). However, Van ECK sold 226,448 shares — a notable institutional exit. The earnings had beaten estimates and management hiked 2026 guidance, so the sell-off seems like valuation compression rather than a fundamental problem.
Mixed signals: analyst upgrade + guidance hike vs. institutional selling + still-low grade. The grade says the valuation isn't compelling enough.
The big story is a $400M stock offering priced Sept 1 — the proceeds go to repay a $400M loan. That's dilutive to existing shareholders (more shares outstanding, same assets) but reduces debt, which is a mixed trade-off. An SEC 8-K was filed Sept 2 (likely related to the offering). Seeking Alpha notes the deal spread on TXNM's pending acquisition may be thin given regulatory presence.
The equity raise is a real event — not positive for existing holders in the short term, but deleveraging is healthy long-term. The acquisition uncertainty adds another layer of risk.
A triple-net-lease REIT that keeps appearing in dividend/income stock lists. Seeking Alpha calls it a "high-yield retail triple net to own." Multiple articles compare it to peers like Realty Income and Agree Realty on payout coverage. No material negative news, just slow-and-steady dividend income positioning.
No new catalyst. The low grade is driven by valuation/growth, not business distress — this is a stable but expensive income play.
Honest limits: SEC.gov blocked direct access to the 8-K filings for CF, LULU, and RJF (403 errors). WSJ's CF Industries supply-crunch article was also blocked. Several Yahoo Finance articles loaded only the page shell without body text — summaries for those relied on headlines, context from related articles, and available snippets. Google News redirect links (for Simply Wall St, MarketBeat, etc.) typically only yield the SPA shell and could not be read in full. This is a once-a-morning read of free sources — not comprehensive research.
MarketMind is a personal, educational stock-research tool. Every morning it screens roughly 900 large- and mid-cap U.S. companies, grades each one from 0–100 on five research-backed pillars — financial health, profitability, growth, valuation, and moat — and surfaces the businesses that look strong and reasonably priced.
The idea it rests on: over the long run, a stock's price follows the company's profits. So rather than chasing hype, MarketMind looks for great businesses at fair prices and lets time do the work.
It also runs a Paper Fund — a fictional $100,000 that automatically follows the tool's own Buy ratings — so you can watch, over time, whether the picks actually work. It's pretend money: nothing here is ever bought or sold for real.
Built with free public data · refreshed every morning at 7:00 AM U.S. Central time.